Women's Tumor Marker Panel

Details of the Tests:

1. Cancer Antigen 125 (CA 125):
- This test is used to measure the level of CA 125 in the blood, a protein typically produced in embryonic cells and contributes to identifying the presence of ovarian cancer. An elevated CA 125 level is a potential indicator of ovarian cancer or other medical conditions.

  2. Cancer Antigen 15.3 (CA 15-3):
- This test is used to measure the level of CA 15-3, a marker indicating the presence of breast cancer. It is usually employed to monitor patients already diagnosed with breast cancer or in cases of reassessing disease progression.

  3. Cancer Antigen 19.9 (CA 19-9):
- This test measures the level of CA 19-9, primarily used to evaluate pancreatic cancer. An elevated CA 19-9 level may indicate the presence of a tumor, but it can also rise in other non-cancerous conditions.

  4. Carcinoembryonic Antigen (CEA):
- This test measures the level of CEA, a protein often produced in embryonic tissues. CEA is used as a marker for diagnosing and monitoring certain types of cancers, including breast cancer and colon cancer.

  5. Alpha Fetoprotein (AFP):
- This test measures the level of AFP, a protein produced by the liver and intestines during pregnancy. An elevated AFP level may indicate the presence of a liver tumor or testicular cancer, and it is also used for monitoring certain cancer types.

Conclusion:
These tests provide a comprehensive view of the patient's condition regarding cancer, enabling doctors to make more effective treatment decisions. By examining biomarker levels, it is possible to detect cancerous tumors at earlier stages and improve treatment opportunities.